Dr. Sarah M. Cork is a member of the Litigation Department and the Life Sciences Group in Proskauer’s Los Angeles office.
Her practice focuses on patent litigation in the life sciences sector, with an emphasis on pharmaceutical, medical device, Hatch-Waxman, and BPCIA matters, and she has represented both patentees and patent challengers in district courts and at the Federal Circuit. Leveraging her extensive scientific training, Sarah understands her clients’ technology at a deep level, and she is skilled at translating complex technical concepts for a lay audience. Select notable representations have concerned the drug products Avastin®, Rituxan®, Kadcyla®, Cialis®, Latuda®, and Lantus®.
Sarah has significant experience with all phases of litigation from pre-suit diligence through trial and appeal, including day-to-day case management, motion practice, fact and expert discovery, witness preparation, taking and defending depositions, and arguing discovery matters in court. Before joining Proskauer, she was an associate at Fish & Richardson P.C.
Prior to her legal career, Sarah conducted research on neurological development and disorders. Her graduate thesis work characterized novel biologic therapeutics for aggressive brain tumors.
Sarah maintains an active pro bono practice relating to children with health concerns, including in Michigan Law’s Pediatric Advocacy Clinic. She also interned in the chambers of the Hon. Anthony Porcelli (M.D. Fla.).